HUT65445A - Process for preparation of thiazolyl-substituted quinolinyl-methoxy-phenyl acetic acid derivatives and pharmaceuticals containing them - Google Patents
Process for preparation of thiazolyl-substituted quinolinyl-methoxy-phenyl acetic acid derivatives and pharmaceuticals containing themInfo
- Publication number
- HUT65445A HUT65445A HU9203812A HU9203812A HUT65445A HU T65445 A HUT65445 A HU T65445A HU 9203812 A HU9203812 A HU 9203812A HU 9203812 A HU9203812 A HU 9203812A HU T65445 A HUT65445 A HU T65445A
- Authority
- HU
- Hungary
- Prior art keywords
- thiazolyl
- methoxy
- preparation
- acetic acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4139751A DE4139751A1 (de) | 1991-12-03 | 1991-12-03 | Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate |
CA002061538A CA2061538A1 (en) | 1991-02-22 | 1992-02-19 | 2-substituted quinolines, processes for their preparation and their use in medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
HUT65445A true HUT65445A (en) | 1994-06-28 |
Family
ID=25674978
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9203812A HU9203812D0 (en) | 1991-12-03 | 1992-12-02 | Quinoline-metoxi-phenyl acetic acid derivatives substituted with thiazolyl group |
HU9203812A HUT65445A (en) | 1991-12-03 | 1992-12-02 | Process for preparation of thiazolyl-substituted quinolinyl-methoxy-phenyl acetic acid derivatives and pharmaceuticals containing them |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9203812A HU9203812D0 (en) | 1991-12-03 | 1992-12-02 | Quinoline-metoxi-phenyl acetic acid derivatives substituted with thiazolyl group |
Country Status (10)
Country | Link |
---|---|
US (1) | US5283252A (hu) |
EP (1) | EP0549879A3 (hu) |
JP (1) | JPH05247036A (hu) |
AU (1) | AU660742B2 (hu) |
CA (2) | CA2061538A1 (hu) |
DE (1) | DE4139751A1 (hu) |
FI (1) | FI925469A (hu) |
HU (2) | HU9203812D0 (hu) |
NZ (1) | NZ245328A (hu) |
ZA (1) | ZA929330B (hu) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4139750A1 (de) * | 1991-12-03 | 1993-06-09 | Bayer Ag, 5090 Leverkusen, De | Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe |
DE4443892A1 (de) * | 1994-12-09 | 1996-06-13 | Bayer Ag | 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate |
US20060019269A1 (en) * | 2002-10-17 | 2006-01-26 | Decode Genetics, Inc. | Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment |
JP2006508180A (ja) * | 2002-10-17 | 2006-03-09 | デコード ジェネティクス イーエッチエフ. | 心筋梗塞に対する感受性遺伝子;治療の方法 |
EP1660427A4 (en) | 2003-08-14 | 2006-12-20 | Asahi Kasei Pharma Corp | SUBSTITUTED ARYLALKANIC DERIVATIVE AND ITS USE |
CA2547518A1 (en) | 2003-12-12 | 2005-06-30 | Wyeth | Quinolines useful in treating cardiovascular disease |
US8158362B2 (en) | 2005-03-30 | 2012-04-17 | Decode Genetics Ehf. | Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype |
CA2553928A1 (en) * | 2004-01-30 | 2005-08-18 | Decode Genetics Ehf. | Susceptibility gene for myocardial infarction, stroke, and paod; methods of treatment |
WO2008067566A1 (en) | 2006-11-30 | 2008-06-05 | Amira Pharmaceuticals, Inc. | Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators |
EP3906925A1 (en) | 2014-02-04 | 2021-11-10 | Bioscience Pharma Partners, LLC | Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE520668A (hu) * | 1956-06-28 | |||
US4725619A (en) * | 1985-04-16 | 1988-02-16 | Usv Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
US4728668A (en) * | 1985-04-16 | 1988-03-01 | Usv Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
US4631287A (en) * | 1985-04-16 | 1986-12-23 | Usv Pharmaceutical Corp. | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
US4839369A (en) * | 1985-04-16 | 1989-06-13 | Rorer Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
US4868193A (en) * | 1986-09-24 | 1989-09-19 | Rorer Pharmaceutical Corporation | Styryl tetrazoles and anti-allergic use thereof |
KR870008853A (ko) * | 1986-03-28 | 1987-10-21 | 오쯔까 아끼히꼬 | 하이드로퀴놀린 화합물의 제조방법 |
DE3814504A1 (de) * | 1988-04-29 | 1989-11-09 | Bayer Ag | (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
DE3900261A1 (de) * | 1988-05-31 | 1989-12-07 | Bayer Ag | Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate |
ZA894913B (en) * | 1988-07-12 | 1990-03-28 | Ici Pharma | Heterocyclic compounds |
US5089495A (en) * | 1989-01-30 | 1992-02-18 | Imperial Chemical Industries Plc | Heterocyclic thiazole derivatives and pharmaceutical compositions comprising said derivatives |
DE3916663A1 (de) * | 1989-05-23 | 1990-11-29 | Bayer Ag | Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
-
1991
- 1991-12-03 DE DE4139751A patent/DE4139751A1/de not_active Withdrawn
-
1992
- 1992-02-19 CA CA002061538A patent/CA2061538A1/en not_active Abandoned
- 1992-11-20 EP EP19920119778 patent/EP0549879A3/de not_active Withdrawn
- 1992-11-23 US US07/979,755 patent/US5283252A/en not_active Expired - Fee Related
- 1992-11-30 JP JP4341035A patent/JPH05247036A/ja active Pending
- 1992-11-30 CA CA002084131A patent/CA2084131A1/en not_active Abandoned
- 1992-12-01 NZ NZ245328A patent/NZ245328A/en unknown
- 1992-12-01 FI FI925469A patent/FI925469A/fi unknown
- 1992-12-01 AU AU29798/92A patent/AU660742B2/en not_active Expired - Fee Related
- 1992-12-02 HU HU9203812A patent/HU9203812D0/hu unknown
- 1992-12-02 ZA ZA929330A patent/ZA929330B/xx unknown
- 1992-12-02 HU HU9203812A patent/HUT65445A/hu unknown
Also Published As
Publication number | Publication date |
---|---|
AU660742B2 (en) | 1995-07-06 |
CA2061538A1 (en) | 1993-08-20 |
FI925469A (fi) | 1993-06-04 |
JPH05247036A (ja) | 1993-09-24 |
CA2084131A1 (en) | 1993-06-04 |
US5283252A (en) | 1994-02-01 |
HU9203812D0 (en) | 1993-03-29 |
AU2979892A (en) | 1993-06-10 |
DE4139751A1 (de) | 1993-06-09 |
EP0549879A2 (de) | 1993-07-07 |
NZ245328A (en) | 1995-02-24 |
ZA929330B (en) | 1993-06-04 |
EP0549879A3 (de) | 1993-07-14 |
FI925469A0 (fi) | 1992-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9303521D0 (en) | Process for producing carboxylic acid derivatives and pharmaceutical compositions containing them | |
PH23202A (en) | 2-(5-fluoronicotinoyl) acetic acid derivatives and process of preparation thereof | |
ZA937502B (en) | Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
HUT63632A (en) | Process for producing 5-amino-4-hydroxyhexanoic acid derivatives and pharmaceutical compositions comprising same | |
HU9202145D0 (en) | Method for producing 7-aza-iso-indolinyl-quinolone derivatives and ones of naphtyridone-carboxylic acid and medical preparatives containing said compounds | |
HUT65204A (en) | Process for producing pyrazolopyrimidine and -triazine derivatives and pharmaceutical preparations containing them | |
IL104446A0 (en) | Acetic acid derivatives,their preparation and pharmaceutical compositions containing them | |
HUT44249A (en) | Process for preparing ascorbic acid derivatives and pharmaceuticals comprising such compounds | |
HUT65486A (en) | Process for producing piperidinyl methylesters of indol-3-carboxylic acid derivatives and pharmaceutical preparations containing them | |
IL105375A0 (en) | Acetic acid derivatives,their preparation and pharmaceutical compositions containing them | |
HUT51277A (en) | Process for producing anellated tetrahydropyridin-acetic acid derivatives and pharmaceutical compositions containing them | |
HUT65445A (en) | Process for preparation of thiazolyl-substituted quinolinyl-methoxy-phenyl acetic acid derivatives and pharmaceuticals containing them | |
AU3088489A (en) | Phenoxyalkylcarboxylic acid derivatives and process for their preparation | |
IL105100A0 (en) | Glutamic acid derivatives and process for their preparation | |
AU649546B2 (en) | Dicarboxylic acid derivatives and process for preparation thereof | |
HU9203867D0 (en) | Method for producing benzoic acid derivatives and pharmaceutical preparatives containing them | |
AU1028892A (en) | Phenoxyalkylcarboxylic acid derivatives and process of preparing the same | |
HUT44242A (en) | Process for preparing substituted toluidine-benzimidazole derivatives and pharmaceuticals comprising such compounds | |
HU895952D0 (en) | Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them | |
HU9203866D0 (en) | Method for producing benzoic acid derivatives and pharmaceutical preparatives containing said compounds | |
HUT70615A (en) | Process for producing acetic acid derivatives and pharmaceutical compositions containing them | |
HUT65850A (en) | Microbiological process for preparation of 5-hydroxi-pyrazin-carbonic acid | |
HU9400325D0 (en) | Process for producing amino-ascorbic acid derivatives and pharmaceutical compositions containing them | |
HUT49615A (en) | Process for producing cefemkarboxylic acid derivatives and pharmaceutical compositions comprising same | |
HUT65224A (en) | Process for producing alkoxymethylsubstituted pyridonbiphenyl derivatives and pharmaceutical preparations containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFA9 | Temporary prot. cancelled due to abandonment |